CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for China BCT Pharmacy Group, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

China BCT Pharmacy Group, Inc.
No. 102, Chengzhan Road
Phone: +86 772363831p:+86 772363831 LIUZHOU, GUX  545007  China Ticker: CNBICNBI
This company ceased filing statements with the SEC on 5/28/2013.
Business Summary
China BCT Pharmacy Group, Inc. is a China-based company engaged in the pharmaceutical distribution, retail pharmacy and manufacturing of pharmaceuticals through its two wholly owned subsidiaries Liuzhou BCT and Hefeng Pharmaceutical as well as BCT Retail, a retail company that it control through a series of contractual arrangements, each of which is located in Guangxi Province, China. The Company operates in three segments: pharmaceutical distribution, retail pharmacy and manufacturing. The Company conducts its wholesale business through Liuzhou BCT. BCT Retail operates a regional retail network in Guangxi province. Hefeng Pharmaceutical has a manufacturing facility located on approximately 40,000 square meters of land.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/201312/31/2012YesYes---

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
1000 Metal mining
5912 Drug stores and proprietary stores
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer Hui Tian T.Tang 51 1/14/2010 12/30/2009
Chief Financial Officer, Director Xiao YanZhang 39 1/14/2010 12/30/2009
Director YunliLou 45 3/17/2011 3/17/2011
3 additional Officers and Directors records available in full report.

Business Names
Business Name
CNBI
Forever Well Asia Pacific Limited
Guangxi Liuzhou Baicaotang Jian Kang Chan Ye Limited
4 additional Business Names available in full report.

General Information
Number of Employees: 1,677 (As of 12/31/2012)
Outstanding Shares: 38,154,340 (As of 12/31/2018)
Shareholders: 107
Stock Exchange: OTC
Federal Tax Id: 208067060
Fax Number: (302) 762-8643


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023